Recursion Releases MolRec, a Compound Intelligence Tool for Drug Discovery, Alongside the Largest of Its Kind Open-Source Dataset During First R&D Day

/PRNewswire/ -- Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, announced the public...

Related Keywords

Montreal ,Quebec ,Canada ,Salt Lake City ,Utah ,United States ,Toronto ,Ontario ,Chris Gibson ,Ben Mabey , ,Compound Intelligence ,Chief Technology Officer ,Chief Executive Officer ,Download Day ,San Francisco Bay ,Recursion ,